Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting EZH2 in SMARCB1-deficient sarcomas: Advances and opportunities to potentiate the efficacy of EZH2 inhibitors
Cinzia Lanzi, Noemi Arrighetti, Sandro Pasquali, et al.
Biochemical Pharmacology (2023) Vol. 215, pp. 115727-115727
Closed Access | Times Cited: 12

Showing 12 citing articles:

A novel case of glial transdifferentiation in renal medullary carcinoma brain metastasis
Maria A. Gubbiotti, Ian E. McCutcheon, Priya Rao, et al.
Acta Neuropathologica Communications (2025) Vol. 13, Iss. 1
Open Access
Epigenetic drugs in cancer therapy
Amila Suraweera, Kenneth J. O’Byrne, Derek J. Richard
Cancer and Metastasis Reviews (2025) Vol. 44, Iss. 1
Open Access
Case report: Molecular characterization of adult atypical teratoid rhabdoid tumor and review of the literature
Miguel A. Hernandez‐Rovira, Michelle Connor, Robert C. Osorio, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Intrathoracic Rhabdoid Tumor: A Rare Site in a Jordanian Infant
Maher Khader, Ruba Alhazaimeh, Mais Jazazi, et al.
Cureus (2025)
Open Access
Non-oncogene dependencies: Novel opportunities for cancer therapy
Tiziana Di Marco, Mara Mazzoni, Angela Greco, et al.
Biochemical Pharmacology (2024) Vol. 228, pp. 116254-116254
Closed Access | Times Cited: 3
Rhabdoid tumor predisposition syndrome: A historical review of treatments and outcomes for associated pediatric malignancies
Sarah Andres, Karen Huang, Margaret Shatara, et al.
Pediatric Blood & Cancer (2024) Vol. 71, Iss. 6
Closed Access | Times Cited: 2
Genetic and Molecular Heterogeneity of Synovial Sarcoma and Associated Challenges in Therapy
Ekaterina A. Lesovaya, Timur I. Fetisov, B. Yu. Bokhyan, et al.
Cells (2024) Vol. 13, Iss. 20, pp. 1695-1695
Open Access | Times Cited: 2
Molecularly Defined Thoracic Neoplasms
Anja C. Roden
Advances in Anatomic Pathology (2024) Vol. 31, Iss. 5, pp. 303-317
Closed Access | Times Cited: 1
Squamous Cell Carcinoma in Never Smokers: An Insight into SMARCB1 Loss
Akshay J. Patel, Hanan Hemead, Hannah Jesani, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8165-8165
Open Access
SWI/SNF-Related Matrix-Associated Actin-Dependent Regulator of Chromatin Subfamily B Member 1 (SMARCB1)-Deficient Tumor in the Parapharyngeal Space: A Case Report
Seiichiro Kamimura, Eiji Kondo, Takahiro Azuma, et al.
Cureus (2024)
Open Access
Targeting heparanase/heparan sulfate proteoglycans by non‐anticoagulant heparins: Opportunities for innovative therapeutic approaches in sarcomas
Cinzia Lanzi, Sandro Pasquali, Giuliana Cassinelli
Proteoglycan Research (2024) Vol. 2, Iss. 4
Open Access
A preface to the special issue “Pediatric tumors”
Giampietro Viola
Biochemical Pharmacology (2023) Vol. 217, pp. 115844-115844
Closed Access
Page 1

Scroll to top